Details of the Drug Formulations

General Information of Drug (ID: DMGVH6N)

Drug Name
Axitinib Drug Info
Synonyms
AG 013736; AG013736; AG-013736; AG-13736; AG-013736, Axitinib; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide; N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; Axitinib (VEGFR inhibitor)
Indication
Disease Entry ICD 11 Status REF
Renal cell carcinoma 2C90 Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
6450551
ChEBI ID
CHEBI:66910
CAS Number
319460-85-0
TTD ID
D01ZRI
VARIDT ID
DR00035
INTEDE ID
DR0162
ACDINA ID
D00053

Full List of Drug Formulations Containing This Drug

Axitinib 1 mg tablet
Company Formulation ID FDA Description
U.S. Pharmaceuticals F02108 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (15000 mpa.s)
Pfizer Laboratories F02109 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Croscarmellose sodium; Hypromellose 2910 (15000 mpa.s); Microcrystalline cellulose
------------------------------------------------------------------------------------
Axitinib 5 mg tablet
Company Formulation ID FDA Description
U.S. Pharmaceuticals F02110 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (15000 mpa.s)
Pfizer Laboratories F02111 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Triacetin; Croscarmellose sodium; Hypromellose 2910 (15000 mpa.s); Microcrystalline cellulose
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5659).